ReviewTranslational lung cancer research2020

Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy.

Zhang-Ru Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.